Sturn W, Sanwald R, Ehninger G
Medizinische Klinik II, Städtischen Krankenhauses Pforzheim, Medizinischen Niversitätsklinik Tübingen.
Dtsch Med Wochenschr. 1989 Mar 3;114(9):337-9. doi: 10.1055/s-2008-1066599.
A 66-year-old woman with ovarian cancer which had metastasized was receiving chemotherapy with cisplatin and cyclophosphamide while undergoing haemodialysis for chronic renal failure. Cisplatin concentration in plasma was measured by flameless atomic absorption spectroscopy. After infusion of 40 mg cisplatin/m2 body-surface peak levels of 2.06 micrograms/ml and 2.29 micrograms/ml were obtained after the second and third treatment cycles, respectively. Terminal half-life was 14 days. Clearance value during haemodialysis was 470 ml/min. Seven treatment cycles were administered, up to doses of 60 mg/m2 cisplatin and 600 mg/m2 cyclophosphamide. Complete remission occurred after five treatment cycles. But the patient died 22 months after onset of treatment from an acute non-A, non-B hepatitis.
一名66岁患有转移性卵巢癌的女性,在因慢性肾衰竭接受血液透析的同时,正在接受顺铂和环磷酰胺化疗。通过无火焰原子吸收光谱法测量血浆中的顺铂浓度。在输注40mg顺铂/m²体表面积后,在第二个和第三个治疗周期后分别获得了2.06μg/ml和2.29μg/ml的峰值水平。终末半衰期为14天。血液透析期间的清除率值为470ml/min。共进行了七个治疗周期,顺铂剂量高达60mg/m²,环磷酰胺剂量高达600mg/m²。五个治疗周期后实现了完全缓解。但患者在治疗开始后22个月死于急性非甲非乙型肝炎。